HEADER COAGULATION FACTOR 23-AUG-96 1FAX TITLE COAGULATION FACTOR XA INHIBITOR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: FACTOR XA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: STUART FACTOR; COMPND 5 EC: 3.4.21.6; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: FACTOR XA; COMPND 10 CHAIN: L; COMPND 11 SYNONYM: STUART FACTOR; COMPND 12 EC: 3.4.21.6; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 TISSUE: BLOOD KEYWDS GLYCOPROTEIN, HYDROLASE, SERINE PROTEASE, PLASMA, BLOOD COAGULATION KEYWDS 2 FACTOR, GAMMA-CARBOXYGLUTAMIC ACID, CALCIUM-BINDING, COAGULATION KEYWDS 3 FACTOR EXPDTA X-RAY DIFFRACTION AUTHOR H.BRANDSTETTER,R.A.ENGH REVDAT 4 16-OCT-24 1FAX 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1FAX 1 VERSN REVDAT 2 01-APR-03 1FAX 1 JRNL REVDAT 1 29-OCT-97 1FAX 0 JRNL AUTH H.BRANDSTETTER,A.KUHNE,W.BODE,R.HUBER,W.VON DER SAAL, JRNL AUTH 2 K.WIRTHENSOHN,R.A.ENGH JRNL TITL X-RAY STRUCTURE OF ACTIVE SITE-INHIBITED CLOTTING FACTOR XA. JRNL TITL 2 IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION. JRNL REF J.BIOL.CHEM. V. 271 29988 1996 JRNL REFN ISSN 0021-9258 JRNL PMID 8939944 JRNL DOI 10.1074/JBC.271.47.29988 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.BRANDSTETTER,M.BAUER,R.HUBER,P.LOLLAR,W.BODE REMARK 1 TITL X-RAY STRUCTURE OF CLOTTING FACTOR IXA: ACTIVE SITE AND REMARK 1 TITL 2 MODULE STRUCTURE RELATED TO XASE ACTIVITY AND HEMOPHILIA B REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 92 9796 1995 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.PADMANABHAN,K.P.PADMANABHAN,A.TULINSKY,C.H.PARK,W.BODE, REMARK 1 AUTH 2 R.HUBER,D.T.BLANKENSHIP,A.D.CARDIN,W.KISIEL REMARK 1 TITL STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 232 947 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH S.KATAKURA,T.NAGAHARA,T.HARA,M.IWAMOTO REMARK 1 TITL A NOVEL FACTOR XA INHIBITOR: STRUCTURE-ACTIVITY REMARK 1 TITL 2 RELATIONSHIPS AND SELECTIVITY BETWEEN FACTOR XA AND THROMBIN REMARK 1 REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 197 965 1993 REMARK 1 REFN ISSN 0006-291X REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 7087 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2266 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 2.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1FAX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173213. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-95 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SAINT REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.11800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.46500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.54000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.58500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.54000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.46500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.58500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 EGF1 DOMAIN IS DISORDERED IN THE CRYSTAL. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 246 REMARK 465 LEU A 247 REMARK 465 PRO A 248 REMARK 465 LYS A 249 REMARK 465 ALA A 250 REMARK 465 LYS A 251 REMARK 465 SER A 252 REMARK 465 HIS A 253 REMARK 465 ALA A 254 REMARK 465 PRO A 255 REMARK 465 GLU A 256 REMARK 465 VAL A 257 REMARK 465 ILE A 258 REMARK 465 THR A 259 REMARK 465 SER A 260 REMARK 465 SER A 261 REMARK 465 PRO A 262 REMARK 465 LEU A 263 REMARK 465 LYS A 264 REMARK 465 TYR L 44 REMARK 465 LYS L 45 REMARK 465 ASP L 46 REMARK 465 GLY L 47 REMARK 465 ASP L 48 REMARK 465 GLN L 49 REMARK 465 CYS L 50 REMARK 465 GLU L 51 REMARK 465 THR L 52 REMARK 465 SER L 53 REMARK 465 PRO L 54 REMARK 465 CYS L 55 REMARK 465 GLN L 56 REMARK 465 ASN L 57 REMARK 465 GLN L 58 REMARK 465 GLY L 59 REMARK 465 LYS L 60 REMARK 465 CYS L 61 REMARK 465 LYS L 62 REMARK 465 ASP L 63 REMARK 465 GLY L 64 REMARK 465 LEU L 65 REMARK 465 GLY L 66 REMARK 465 GLU L 67 REMARK 465 TYR L 68 REMARK 465 THR L 69 REMARK 465 CYS L 70 REMARK 465 THR L 71 REMARK 465 CYS L 72 REMARK 465 LEU L 73 REMARK 465 GLU L 74 REMARK 465 GLY L 75 REMARK 465 PHE L 76 REMARK 465 GLU L 77 REMARK 465 GLY L 78 REMARK 465 LYS L 79 REMARK 465 ASN L 80 REMARK 465 CYS L 81 REMARK 465 GLU L 82 REMARK 465 LEU L 83 REMARK 465 PHE L 84 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 63 CB CG CD NE CZ NH1 NH2 REMARK 480 ARG A 150 CB CG CD NE CZ NH1 NH2 REMARK 480 LYS A 243 NZ REMARK 480 ARG A 245 O CB CG CD NE CZ NH1 REMARK 480 ARG A 245 NH2 REMARK 480 LYS L 87 CB CG CD CE NZ REMARK 480 LEU L 91 CB CG CD1 CD2 REMARK 480 ASP L 92 OD1 OD2 REMARK 480 HIS L 101 CG ND1 CD2 CE1 NE2 REMARK 480 GLU L 102 OE2 REMARK 480 GLU L 103 CG CD OE1 OE2 REMARK 480 GLN L 104 CB CG CD OE1 NE2 REMARK 480 ALA L 105 CA C O CB REMARK 480 ARG L 113 NH2 REMARK 480 ASP L 119 OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP A 127 CA - C - N ANGL. DEV. = -13.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 56 -59.78 -15.82 REMARK 500 GLU A 77 33.06 -82.20 REMARK 500 ASN A 92 -10.88 -44.56 REMARK 500 PHE A 94 103.81 -57.88 REMARK 500 ASN A 117 10.14 89.77 REMARK 500 PRO A 124 -166.38 -78.56 REMARK 500 TRP A 127 73.70 81.87 REMARK 500 ALA A 128 -70.99 165.80 REMARK 500 SER A 130 148.78 76.66 REMARK 500 THR A 131 -76.38 66.04 REMARK 500 ARG A 143 130.88 -36.71 REMARK 500 HIS A 145 -2.47 -156.47 REMARK 500 GLU A 147 119.63 63.98 REMARK 500 GLN A 151 -86.27 -68.77 REMARK 500 SER A 152 -54.59 -160.24 REMARK 500 THR A 153 -51.98 69.45 REMARK 500 GLN A 178 3.00 -67.56 REMARK 500 ASP A 189 160.41 174.31 REMARK 500 ASP A 205 -20.01 66.94 REMARK 500 SER A 214 -75.91 -102.94 REMARK 500 LYS A 223 107.87 -57.63 REMARK 500 THR A 244 99.46 107.51 REMARK 500 LYS L 87 -168.99 178.32 REMARK 500 LEU L 88 98.32 74.44 REMARK 500 SER L 90 -71.59 -66.73 REMARK 500 LEU L 91 -65.60 -8.60 REMARK 500 ASP L 92 57.24 -163.73 REMARK 500 GLN L 98 -108.68 -133.26 REMARK 500 GLN L 104 -80.87 64.58 REMARK 500 VAL L 108 98.97 61.93 REMARK 500 LYS L 122 -44.84 -132.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 1 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 70 OD1 REMARK 620 2 ASN A 72 O 65.8 REMARK 620 3 ALA A 75 O 162.8 122.0 REMARK 620 4 GLU A 80 OE2 82.2 130.8 81.7 REMARK 620 5 GLU A 80 OE1 71.7 135.2 102.7 52.5 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC CENTER OF SERINE PROTEASE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DX9 A 265 DBREF 1FAX A 16 264 UNP P00742 FA10_HUMAN 235 481 DBREF 1FAX L 44 139 UNP P00742 FA10_HUMAN 84 179 SEQADV 1FAX ALA A 74 UNP P00742 GLU 294 CONFLICT SEQADV 1FAX ALA A 75 UNP P00742 GLN 295 CONFLICT SEQADV 1FAX ALA L 105 UNP P00742 ASN 145 CONFLICT SEQRES 1 A 254 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 A 254 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 A 254 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 A 254 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 A 254 ARG VAL GLY ASP ARG ASN THR ALA ALA GLU GLU GLY GLY SEQRES 6 A 254 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 A 254 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 A 254 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 A 254 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 A 254 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 A 254 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 A 254 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 A 254 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 A 254 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 A 254 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 A 254 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 A 254 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 A 254 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 A 254 ARG GLY LEU PRO LYS ALA LYS SER HIS ALA PRO GLU VAL SEQRES 20 A 254 ILE THR SER SER PRO LEU LYS SEQRES 1 L 96 TYR LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN SEQRES 2 L 96 ASN GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR SEQRES 3 L 96 CYS THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU SEQRES 4 L 96 LEU PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP SEQRES 5 L 96 CYS ASP GLN PHE CYS HIS GLU GLU GLN ALA SER VAL VAL SEQRES 6 L 96 CYS SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY SEQRES 7 L 96 LYS ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS SEQRES 8 L 96 GLN THR LEU GLU ARG HET CA A 1 1 HET DX9 A 265 39 HETNAM CA CALCIUM ION HETNAM DX9 (2S)-3-(7-CARBAMIMIDOYLNAPHTHALEN-2-YL)-2-[4-({(3R)-1- HETNAM 2 DX9 [(1Z)-ETHANIMIDOYL]PYRROLIDIN-3-YL}OXY) HETNAM 3 DX9 PHENYL]PROPANOIC ACID HETSYN DX9 DX9056A FORMUL 3 CA CA 2+ FORMUL 4 DX9 C26 H28 N4 O3 HELIX 1 1 ALA A 56 TYR A 60 5 5 HELIX 2 2 ARG A 165 SER A 171 1 7 HELIX 3 3 VAL A 231 ALA A 233 5 3 HELIX 4 4 LEU A 235 LYS A 243 1 9 HELIX 5 5 ASN L 93 ASP L 95 5 3 SHEET 1 A 4 ALA A 81 GLU A 84 0 SHEET 2 A 4 PHE A 64 VAL A 68 -1 N VAL A 68 O ALA A 81 SHEET 3 A 4 GLN A 30 ASN A 35 -1 N ILE A 34 O LYS A 65 SHEET 4 A 4 GLY A 40 THR A 45 -1 N GLY A 44 O ALA A 31 SHEET 1 B 3 TYR A 51 THR A 54 0 SHEET 2 B 3 ALA A 104 LEU A 108 -1 N LEU A 106 O ILE A 52 SHEET 3 B 3 VAL A 85 LYS A 90 -1 N ILE A 89 O VAL A 105 SHEET 1 C 2 THR A 135 GLY A 140 0 SHEET 2 C 2 LYS A 156 PRO A 161 -1 N VAL A 160 O GLY A 136 SHEET 1 D 4 MET A 180 ALA A 183 0 SHEET 2 D 4 GLY A 226 LYS A 230 -1 N TYR A 228 O PHE A 181 SHEET 3 D 4 THR A 206 GLY A 216 -1 N TRP A 215 O ILE A 227 SHEET 4 D 4 PRO A 198 PHE A 203 -1 N PHE A 203 O THR A 206 SHEET 1 E 2 TYR L 115 LEU L 117 0 SHEET 2 E 2 CYS L 124 PRO L 126 -1 N ILE L 125 O THR L 116 SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.02 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.01 SSBOND 3 CYS A 122 CYS L 132 1555 1555 2.02 SSBOND 4 CYS A 168 CYS A 182 1555 1555 2.01 SSBOND 5 CYS A 191 CYS A 220 1555 1555 2.01 SSBOND 6 CYS L 89 CYS L 100 1555 1555 2.02 SSBOND 7 CYS L 96 CYS L 109 1555 1555 2.02 SSBOND 8 CYS L 111 CYS L 124 1555 1555 2.02 LINK CA CA A 1 OD1 ASP A 70 1555 1555 2.96 LINK CA CA A 1 O ASN A 72 1555 1555 1.99 LINK CA CA A 1 O ALA A 75 1555 1555 2.28 LINK CA CA A 1 OE2 GLU A 80 1555 1555 2.12 LINK CA CA A 1 OE1 GLU A 80 1555 1555 2.65 SITE 1 CAT 3 HIS A 57 ASP A 102 SER A 195 SITE 1 AC1 5 ASP A 70 ASN A 72 ALA A 75 GLU A 77 SITE 2 AC1 5 GLU A 80 SITE 1 AC2 9 GLU A 97 ASP A 189 ALA A 190 CYS A 191 SITE 2 AC2 9 GLN A 192 TRP A 215 GLY A 216 GLY A 218 SITE 3 AC2 9 GLY A 226 CRYST1 56.930 73.170 79.080 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017565 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013667 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012645 0.00000